DNA Shed From Colon Cancers Into Bloodstream Guide Chemotherapy

A new research study showed that circulating tumor DNA (ctDNA) — genetic material shed from tumors into the bloodstream — can identify those stage II colon cancer patients who can most benefit from chemotherapy following surgery. Learn more about this study and how patients will benefit.

Recent Posts

Study Shows Patient/Clinician Identity Differences Are Factor in Cancer Care Study Finds Diverse Differences in Microbes in Breast Tumors From Women of Different Races Nutrition Fact, Fiction or Somewhere in Between? ‘Hard To Lose’ Mutations In Tumors May Predict Response To Immunotherapy What are dense breasts? New Blood Test for Cancer The Best Way to Take A Pill, According to Science 8 Ways to Lose Belly Fat and Live a Healthier Life Sunglasses Are More Than Just a Fashion Accessory